Clinical Trial Update: G.I. Pharmacokinetics of LMN-401 in Individuals With Ileostomies [EARLY_Phase 1]

View source ↗

Summary

An early-phase 1 study to characterize the gastrointestinal pharmacokinetics of LMN-401 in individuals with ileostomies. The study is sponsored by Lumen Bioscie…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Travelers Diarrhea

Drugs mentioned

• LMN-401

Snippet

Sponsor: Lumen Bioscience, Inc. | Conditions: Travelers Diarrhea | EARLY_Phase 1 | Status: RECRUITING